Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Apnimed, Inc.
New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment
November 19, 2026
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 16, 2026
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 5, 2026
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
October 12, 2026
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
September 8, 2026
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 4, 2026
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 3, 2026
Apnimed Announces Pricing of Upsized Initial Public Offering
July 30, 2026
Apnimed Announces FDA Acceptance of New Drug Application for AD109, An Investigational Oral Pill to Treat Adults with Obstructive Sleep Apnea (OSA)
July 14, 2026
1
2
Next Page
→